BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22127362)

  • 21. Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
    Lee HN; Lee KH; Lee DW; Lee YS; Park EK; Park JS
    Int J Gynecol Cancer; 2011 Jan; 21(1):128-36. PubMed ID: 21330837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.
    Ferrandina G; Palluzzi E; Gallotta V; Gambacorta MA; Autorino R; Turco LC; Macchia G; Cosentino F; Gui B; Mattoli MV; Ronzino G; Valentini V; Scambia G
    Eur J Surg Oncol; 2018 Jul; 44(7):1062-1068. PubMed ID: 29753611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer.
    Di Donato V; Schiavi MC; Ruscito I; Visentin VS; Palaia I; Marchetti C; Fischetti M; Monti M; Muzii L; Benedetti Panici P
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):841-849. PubMed ID: 27678502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer.
    Morice P; Rouanet P; Rey A; Romestaing P; Houvenaeghel G; Boulanger JC; Leveque J; Cowen D; Mathevet P; Malhaire JP; Magnin G; Fondrinier E; Berille J; Haie-Meder C
    Oncologist; 2012; 17(1):64-71. PubMed ID: 22234626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helical tomotherapy in cervical cancer patients: simultaneous integrated boost concept: technique and acute toxicity.
    Marnitz S; Stromberger C; Kawgan-Kagan M; Wlodarczyk W; Jahn U; Schneider A; Ulrich U; Budach V; Köhler C
    Strahlenther Onkol; 2010 Oct; 186(10):572-9. PubMed ID: 20936458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.
    Keys HM; Bundy BN; Stehman FB; Muderspach LI; Chafe WE; Suggs CL; Walker JL; Gersell D
    N Engl J Med; 1999 Apr; 340(15):1154-61. PubMed ID: 10202166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
    Delpech Y; Haie-Meder C; Rey A; Zafrani Y; Uzan C; Gouy S; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
    Ann Surg Oncol; 2007 Nov; 14(11):3223-31. PubMed ID: 17713822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective phase I/II study of irradiation and concurrent chemotherapy for recurrent cervical cancer after radical hysterectomy.
    Grigsby PW
    Int J Gynecol Cancer; 2004; 14(5):860-4. PubMed ID: 15361195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neoadjuvant radiochemotherapy and surgery of locally advanced cervical carcinoma: review of 22 patients treated at the Bordet Institute].
    Noterman D; Philippson C; Hertens D; Veys I; Schobbens JC; Nogaret JM
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1):23-7. PubMed ID: 16446608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could lymphadenectomy be avoided in locally advanced cervical cancer patients administered preoperative chemoradiation? A large-scale retrospective study.
    Ferrandina G; Distefano M; Mascilini F; Gallotta V; Chiantera V; Cosentino F; Costantini B; Ercoli A; Pedone Anchora L; Fanfani F; Margariti AP; Valentini V; Scambia G
    Eur J Surg Oncol; 2017 Dec; 43(12):2270-2276. PubMed ID: 28988767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robotic Radical Parametrectomy With Upper Vaginectomy and Pelvic Lymphadenectomy in Patients With Occult Cervical Carcinoma After Extrafascial Hysterectomy.
    Tran AQ; Sullivan SA; Gehrig PA; Soper JT; Boggess JF; Kim KH
    J Minim Invasive Gynecol; 2017; 24(5):757-763. PubMed ID: 28254677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
    Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
    Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1).
    Macchia G; Ferrandina G; Deodato F; Ruggieri V; Massaccesi M; Salutari V; Valentini V; Cellini N; Scambia G; Morganti AG
    Gynecol Oncol; 2010 Aug; 118(2):128-33. PubMed ID: 20494419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study.
    Ferrandina G; Gambacorta A; Gallotta V; Smaniotto D; Fagotti A; Tagliaferri L; Foti E; Fanfani F; Autorino R; Scambia G; Valentini V
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):778-85. PubMed ID: 25585781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer.
    Miglietta L; Franzone P; Centurioni MG; Boni L; Tacchini L; Cosso M; Boccardo F; Ferrarini M; Bruzzone M
    Oncology; 2006; 70(1):19-24. PubMed ID: 16439862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging.
    Marnitz S; Köhler C; Roth C; Füller J; Bischoff A; Wendt T; Schneider A; Budach V
    Strahlenther Onkol; 2007 Sep; 183(9):473-8. PubMed ID: 17762920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy.
    Ziebarth AJ; Smith H; Killian ME; Nguyen NA; Durst JK; Subramaniam A; Kim KH; Leath CA; Straughn JM; Alvarez RD
    Gynecol Oncol; 2012 Jul; 126(1):69-72. PubMed ID: 22484400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidermoid carcinoma of the uterine cervix at operable bulky stages IB and II treated with combined primary radiation therapy and surgery].
    Bernard A; Touboul E; Lefranc JP; Deniaud-Alexandre E; Genestie C; Uzan S; Blondon J
    Cancer Radiother; 2002 Apr; 6(2):85-98. PubMed ID: 12035486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.
    Folkert MR; Shih KK; Abu-Rustum NR; Jewell E; Kollmeier MA; Makker V; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Feb; 128(2):288-93. PubMed ID: 23159818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weekly versus triweekly cisplatin-alone adjuvant chemoradiotherapy after radical hysterectomy for stages IB-IIA cervical cancer with risk of recurrence.
    Zhu J; Lou R; Ji S; Wu G; Chen Q; Hu Q; Zhao Y; Cai D; Gu K
    Anticancer Drugs; 2021 Feb; 32(2):203-209. PubMed ID: 33186140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.